SLC5A5 and neoplasm: In particular, a study by Packiriswamy et al. investigated primary T cell responses against a known panel of tumor-associated antigens (TAAs) in MM, after administration of oncolytic MV encoding sodium iodide symporter (MV-NIS) [78].